Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy

Planta Medica

Volumn 75, Issue 15, 2009, Pages 1549-1560

  Laszczyk, Melanie N ^a,b  

^a Betulin Institute   (Germany)

^b Carl Gustav Carus Institut   (Germany)

Author keywords

Cancer treatment; Multifunctional agent; Pentacyclic triterpenes

Indexed keywords

APOPTOSIS INDUCING FACTOR; BETULIC ACID; BETULIN; CISPLATIN; ERYTHRODIOL; IMMUNOMODULATING AGENT; LUPEOL; OLEANOLIC ACID; PENTACYCLIC TRITERPENE; PLANT EXTRACT; URSOLIC ACID;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BREAST CANCER; CANCER CELL; CANCER THERAPY; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC INFLAMMATION; COLON CANCER; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; LUNG CANCER; MELANOMA; MELANOMA CELL; METABOLITE; MICROENVIRONMENT; NEUROBLASTOMA; NONHUMAN; PLANT; REVIEW; TONGUE CARCINOMA; TUMOR XENOGRAFT;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; HUMANS; NEOPLASMS; OLEANOLIC ACID; PENTACYCLIC TRITERPENES; PHYTOTHERAPY; PLANT EXTRACTS; TRITERPENES;

MALUS X DOMESTICA; ROSMARINUS OFFICINALIS;

EID: 74049157757     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1186102     Document Type: Review

References (134)

1. Trosko J E. The role of stem cells and gap junctions as targets for cancer chemoprevention and chemotherapy. Biomed Pharmacother 2005 59 (Suppl.2) 326-331
2. Brenner D E., Gescher A J. Cancer chemoprevention: lessons learned and future directions. Br J Cancer 2005 93 735-739
3. Xu R, Fazio G C., Matsuda S P. On the origins of triterpenoid skeletal diversity. Phytochemistry 2004 65 261-291
4. Ekman R. The submarin monomers and triterpenoids from the outer bark of Betula verrucosa EHRH. Holzforschung 1983 37 205-211
5. Laszczyk M, Jäger S, Simon-Haarhaus B, Scheffler A, Schempp C M. Physical, chemical and pharmacological characterization of a new oleogel-forming triterpene extract from the outer bark of birch (betulae cortex). Planta Med 2006 72 1389-1395
6. Jäger S, Trojan H, Kopp T, Laszczyk M N., Scheffler A. Pentacyclic triterpene distribution in various plants rich sources for a new group of multi-potent plant extracts. Molecules 2009 14 2016-2031
7. Chaturvedi P K., Bhui K, Shukla Y. Lupeol: connotations for chemoprevention. Cancer Lett 2008 263 1-13
8. Ovesna Z, Vachalkova A, Horvathova K, Tothova D. Pentacyclic triterpenoic acids: new chemoprotective compounds. Minireview. Neoplasma 2004 51 327-333
9. Fulda S. Betulinic acid: a natural product with anticancer activity. Mol Nutr Food Res 2009 53 140-146
10. Fulda S, Jeremias I, Steiner H H., Pietsch T, Debatin K M. Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells. Int J Cancer 1999 82 435-441
11. Galgon T, Wohlrab W, Dräger B. Betulinic acid induces apoptosis in skin cancer cells and differentiation in normal human keratinocytes. Exp Dermatol 2005 14 736-743
12. Kessler J H., Mullauer F B., de Roo G M., Medema J P. Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer types. Cancer Lett 2007 251 132-145
13. Selzer E, Pimentel E, Wacheck V, Schlegel W, Pehamberger H, Jansen B, Kodym R. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells. J Invest Dermatol 2000 114 935-940
14. Zuco V, Supino R, Righetti S C., Cleris L, Marchesi E, Gambacorti-Passerini C, Formelli F. Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett 2002 175 17-25
15. Wachsberger P R., Burd R, Wahl M L., Leeper D B. Betulinic acid sensitization of low pH adapted human melanoma cells to hyperthermia. Int J Hyperthermia 2002 18 153-164
16. Noda Y, Kaiya T, Kohda K, Kawazoe Y. Enhanced cytotoxicity of some triterpenes toward leukemia L1210 cells cultured in low pH media: possibility of a new mode of cell killing. Chem Pharm Bull (Tokyo) 1997 45 1665-1670
17. Fulda S, Scaffidi C, Susin S A., Krammer P H., Kroemer G, Peter M E., Debatin K M. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J Biol Chem 1998 273 33942-33948
18. Tan Y, Yu R, Pezzuto J M. Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation. Clin Cancer Res 2003 9 2866-2875
19. Liu W K., Ho J C., Cheung F W., Liu B P., Ye W C., Che C T. Apoptotic activity of betulinic acid derivatives on murine melanoma B16 cell line. Eur J Pharmacol 2004 498 71-78
20. Martin R, Carvalho J, Ibeas E, Hernandez M, Ruiz-Gutierrez V, Nieto M L. Acidic triterpenes compromise growth and survival of astrocytoma cell lines by regulating reactive oxygen species accumulation. Cancer Res 2007 67 3741-3751
21. Mullauer F B., Kessler J H., Medema J P. Betulinic acid induces cytochrome c release and apoptosis in a Bax/Bak-independent, permeability transition pore dependent fashion. Apoptosis 2009 14 191-202
22. Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nunez G, Krammer P H., Peter M E., Debatin K M. Betulinic acid triggers CD95 (APO-1/Fas)-and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res 1997 57 4956-4964
23. Selzer E, Thallinger C, Hoeller C, Oberkleiner P, Wacheck V, Pehamberger H, Jansen B. Betulinic acid-induced Mcl-1 expression in human melanomamode of action and functional significance. Mol Med 2002 8 877-884
24. Wick W, Grimmel C, Wagenknecht B, Dichgans J, Weller M. Betulinic acid-induced apoptosis in glioma cells: a sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing. J Pharmacol Exp Ther 1999 289 1306-1312
25. Rzeski W, Stepulak A, Szymanski M, Sifringer M, Kaczor J, Wejksza K, Zdzisinska B, Kandefer-Szerszen M. Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells. Naunyn Schmiedebergs Arch Pharmacol 2006 374 11-20
26. Kasperczyk H, La Ferla-Bruhl K, Westhoff M A., Behrend L, Zwacka R M., Debatin K M., Fulda S. Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for cancer therapy. Oncogene 2005 24 6945-6956
27. Rabi T, Shukla S, Gupta S. Betulinic acid suppresses constitutive and TNFalpha-induced NF-kappaB activation and induces apoptosis in human prostate carcinoma PC-3 cells. Mol Carcinogen 2008 47 964-973
28. Saleem M, Kweon M H., Yun J M., Adhami V M., Khan N, Syed D N., Mukhtar H. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model. Cancer Res 2005 65 11203-11213
29. Murtaza I, Saleem M, Adhami V M., Hafeez B B., Mukhtar H. Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells. Cancer Res 2009 69 1156-1165
30. Saleem M, Kaur S, Kweon M H., Adhami V M., Afaq F, Mukhtar H. Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway. Carcinogenesis 2005 26 1956-1964
31. Manu K A., Kuttan G. Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NF-kappaB mediated activation of bcl-2 in B16F-10 melanoma cells. Int Immunopharmacol 2008 8 974-981
32. Zhang P, Li H, Chen D, Ni J, Kang Y, Wang S. Oleanolic acid induces apoptosis in human leukemia cells through caspase activation and poly(ADP-ribose) polymerase cleavage. Acta Biochim Biophys Sin (Shanghai) 2007 39 803-809
33. Kim D S., Pezzuto J M., Pisha E. Synthesis of betulinic acid derivatives with activity against human melanoma. Bioorg Med Chem Lett 1998 8 1707-1712
34. Hata K, Hori K, Ogasawara H, Takahashi S. Anti-leukemia activities of Lup-28-al-20(29)-en-3-one, a lupane triterpene. Toxicol Lett 2003 143 1-7
35. Pyo J S., Roh S H., Kim D K., Lee J G., Lee Y Y., Hong S S., Kwon S W., Park J H. Anti-cancer effect of betulin on a human lung cancer cell line: a pharmacoproteomic approach using 2DSDS PAGE coupled with nano-HPLC tandem mass spectrometry. Planta Med 2009 75 127-131
36. Juan M E., Wenzel U, Daniel H, Planas J M. Erythrodiol, a natural triterpenoid from olives, has antiproliferative and apoptotic activity in HT-29 human adenocarcinoma cells. Mol Nutr Food Res 2008 52 595-599
37. Huyke C, Reuter J, Rodig M, Kersten A, Laszczyk M, Scheffler A, Nashan D, Schempp C. Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot study. J Dtsch Dermatol Ges 2009 7 128-133
38. Sohn K H., Lee H Y., Chung H Y., Young H S., Yi S Y., Kim K W. Anti-angiogenic activity of triterpene acids. Cancer Lett 1995 94 213-218
39. Kiran M S., Viji R I., Sameer Kumar V B., Sudhakaran P R. Modulation of angiogenic factors by ursolic acid. Biochem Biophys Res Commun 2008 371 556-560
40. Cardenas C, Quesada A R., Medina M A. Effects of ursolic acid on different steps of the angiogenic process. Biochem Biophys Res Commun 2004 320 402-408
41. Jedinak A, Muckova M, Kost'alova D, Maliar T, Masterova I. Antiprotease and antimetastatic activity of ursolic acid isolated from Salvia officinalis. Z Naturforsch [C] 2006 61 777-782
42. Melzig M F., Bormann H. Betulinic acid inhibits aminopeptidase N activity. Planta Med 1998 64 655-657
43. Bauvois B, Dauzonne D. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects. Med Res Rev 2006 26 88-130
44. Bhagwat S V., Lahdenranta J, Giordano R, Arap W, Pasqualini R, Shapiro L H. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood 2001 97 652-659
45. Kwon H J., Shim J S., Kim J H., Cho H Y., Yum Y N., Kim S H., Yu J. Betulinic acid inhibits growth factor-induced in vitro angiogenesis via the modulation of mitochondrial function in endothelial cells. Jpn J Cancer Res 2002 93 417-425
46. Lee M S., Moon E J., Lee S W., Kim M S., Kim K W., Kim Y J. Angiogenic activity of pyruvic acid in in vivo and in vitro angiogenesis models. Cancer Res 2001 61 3290-3293
47. Chintharlapalli S, Papineni S, Ramaiah S K., Safe S. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res 2007 67 2816-2823
48. You Y J., Nam N H., Kim Y, Bae K H., Ahn B Z. Antiangiogenic activity of lupeol from Bombax ceiba. Phytother Res 2003 17 341-344
49. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008 454 436-444
50. Ahmad S F., Khan B, Bani S, Suri K A., Satti N K., Qazi G N. Amelioration of adjuvant-induced arthritis by ursolic acid through altered Th1/Th2 cytokine production. Pharmacol Res 2006 53 233-240
51. Altinier G, Sosa S, Aquino R P., Mencherini T, Della Loggia R, Tubaro A. Characterization of topical antiinflammatory compounds in Rosmarinus officinalis L. J Agric Food Chem 2007 55 1718-1723
52. Banno N, Akihisa T, Tokuda H, Yasukawa K, Higashihara H, Ukiya M, Watanabe K, Kimura Y, Hasegawa J, Nishino H. Triterpene acids from the leaves of Perilla frutescens and their anti-inflammatory and antitumor-promoting effects. Biosci Biotechnol Biochem 2004 68 85-90
53. de la Puerta R, Martinez-Dominguez E, Ruiz-Gutierrez V. Effect of minor components of virgin olive oil on topical antiinflammatory assays. Z Naturforsch [C] 2000 55 814-819
54. Fernandez M A., de las Heras B, Garcia M D., Saenz M T., Villar A. New insights into the mechanism of action of the anti-inflammatory triterpene lupeol. J Pharm Pharmacol 2001 53 1533-1539
55. Miceli N, Taviano M F., Giuffrida D, Trovato A, Tzakou O, Galati E M. Anti-inflammatory activity of extract and fractions from Nepeta sibthorpii Bentham. J Ethnopharmacol 2005 97 261-266
56. Recio M C., Giner R M., Manez S, Gueho J, Julien H R., Hostettmann K, Rios J L. Investigations on the steroidal anti-inflammatory activity of triterpenoids from Diospyros leucomelas. Planta Med 1995 61 9-12
57. Alakurtti S, Makela T, Koskimies S, Yli-Kauhaluoma J. Pharmacological properties of the ubiquitous natural product betulin. Eur J Pharm Sci 2006 29 1-13
58. Cichewicz R H., Kouzi S A. L. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med Res Rev 2004 24 90-114
59. Eiznhamer D A., Xu Z Q. Betulinic acid: a promising anticancer candidate. IDrugs 2004 7 359-373
60. Bani S, Kaul A, Khan B, Ahmad S F., Suri K A., Gupta B D., Satti N K., Qazi G N. Suppression of T-lymphocyte activity by lupeol isolated from Crataeva religiosa. Phytother Res 2006 20 279-287
61. Kang S Y., Yoon S Y., Roh D H., Jeon M J., Seo H S., Uh D K., Kwon Y B., Kim H W., Han H J., Lee H J., Lee J H. The anti-arthritic effect of ursolic acid on zymosan-induced acute inflammation and adjuvant-induced chronic arthritis models. J Pharm Pharmacol 2008 60 1347-1354
62. Laszczyk M N. Triterpentrockenextrakt aus Birkenkork (Betula alba cortex) [dissertation]. Freiburg Albert-Ludwigs-University 2007
63. Yun Y, Han S, Park E, Yim D, Lee S, Lee C K., Cho K, Kim K. Immunomodulatory activity of betulinic acid by producing pro-inflammatory cytokines and activation of macrophages. Arch Pharm Res 2003 26 1087-1095
64. Ikeda Y, Murakami A, Fujimura Y, Tachibana H, Yamada K, Masuda D, Hirano K, Yamashita S, Ohigashi H. Aggregated ursolic acid, a natural triterpenoid, induces IL-1beta release from murine peritoneal macrophages: role of CD36. J Immunol 2007 178 4854-4864
65. Marquez-Martin A, De La Puerta R, Fernandez-Arche A, Ruiz-Gutierrez V, Yaqoob P. Modulation of cytokine secretion by pentacyclic triterpenes from olive pomace oil in human mononuclear cells. Cytokine 2006 36 211-217
66. Vasconcelos M A., Royo V A., Ferreira D S., Crotti A E., Andrade e Silva M L., Carvalho J C., Bastos J K., Cunha W R. In vivo analgesic and anti-inflammatory activities of ursolic acid and oleanoic acid from Miconia albicans (Melastomataceae). Z Naturforsch [C] 2006 61 477-482
67. Van Waes C. Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin Cancer Res 2007 13 1076-1082
68. Takada Y, Aggarwal B B. Betulinic acid suppresses carcinogen-induced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9. J Immunol 2003 171 3278-3286
69. Shishodia S, Majumdar S, Banerjee S, Aggarwal B B. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res 2003 63 4375-4383
70. You H J., Choi C Y., Kim J Y., Park S J., Hahm K S., Jeong H G. Ursolic acid enhances nitric oxide and tumor necrosis factor-alpha production via nuclear factor-kappaB activation in the resting macrophages. FEBS Lett 2001 509 156-160
71. Choi C Y., You H J., Jeong H G. L. Nitric oxide and tumor necrosis factor-alpha production by oleanolic acid via nuclear factor-kappaB activation in macrophages. Biochem Biophys Res Commun 2001 288 49-55
72. Suh N, Honda T, Finlay H J., Barchowsky A, Williams C, Benoit N E., Xie Q W., Nathan C, Gribble G W., Sporn M B. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res 1998 58 717-723
73. Bernard P, Scior T, Didier B, Hibert M, Berthon J Y. L. Ethnopharmacology and bioinformatic combination for leads discovery: application to phospholipase A(2) inhibitors. Phytochemistry 2001 58 865-874
74. Dharmappa K K., Kumar R V., Nataraju A, Mohamed R, Shivaprasad H V., Vishwanath B S. Anti-inflammatory activity of oleanolic acid by inhibition of secretory phospholipase A2. Planta Med 2009 75 211-215
75. Reyes C P., Nunez M J., Jimenez I A., Busserolles J, Alcaraz M J., Bazzocchi I L. Activity of lupane triterpenoids from Maytenus species as inhibitors of nitric oxide and prostaglandin E2. Bioorg Med Chem 2006 14 1573-1579
76. Saleem M, Afaq F, Adhami V M., Mukhtar H. Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene 2004 23 5203-5214
77. Telliez A, Furman C, Pommery N, Henichart J P. Mechanisms leading to COX-2 expression and COX-2 induced tumorigenesis: topical therapeutic strategies targeting COX-2 expression and activity. Anticancer Agents Med Chem 2006 6 187-208
78. Valko M, Leibfritz D, Moncol J, Cronin M T., Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007 39 44-84
79. Castelao J E., Gago-Dominguez M. Risk factors for cardiovascular disease in women: relationship to lipid peroxidation and oxidative stress. Med Hypotheses 2008 71 39-44
80. Leitinger N. The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans. Subcell Biochem 2008 49 325-350
81. Valko M, Rhodes C J., Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006 160 1-40
82. Kalpakcioglu B, Senel K. The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis. Clin Rheumatol 2008 27 141-145
83. Afonso V, Champy R, Mitrovic D, Collin P, Lomri A. Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine 2007 74 324-329
84. Fernandes A P., Holmgren A. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal 2004 6 63-74
85. Prasad S, Kalra N, Singh M, Shukla Y. Protective effects of lupeol and mango extract against androgen induced oxidative stress in Swiss albino mice. Asian J Androl 2008 10 313-318
86. Ramachandran S, Prasad N R. Effect of ursolic acid, a triterpenoid antioxidant, on ultraviolet-B radiation-induced cytotoxicity, lipid peroxidation and DNA damage in human lymphocytes. Chem Biol Interact 2008 176 99-107
87. Sudhahar V, Ashok Kumar S, Varalakshmi P, Sujatha V. Protective effect of lupeol and lupeol linoleate in hypercholesterolemia associated renal damage. Mol Cell Biochem 2008 317 11-20
88. Sudharsan P T., Mythili Y, Selvakumar E, Varalakshmi P. Cardioprotective effect of pentacyclic triterpene, lupeol and its ester on cyclophosphamide- induced oxidative stress. Hum Exp Toxicol 2005 24 313-318
89. Sultana S, Saleem M, Sharma S, Khan N. Lupeol, a triterpene, prevents free radical mediated macromolecular damage and alleviates benzoyl peroxide induced biochemical alterations in murine skin. Indian J Exp Biol 2003 41 827-831
90. Malini M M., Lenin M, Varalakshmi P. Protective effect of triterpenes on calcium oxalate crystal-induced peroxidative changes in experimental urolithiasis. Pharmacol Res 2000 41 413-418
91. Geetha T, Varalakshmi P. Anticomplement activity of triterpenes from Crataeva nurvala stem bark in adjuvant arthritis in rats. Gen Pharmacol 1999 32 495-497 (Pubitemid 29192843)
92. Vidya L, Malini M M., Varalakshmi P. Effect of pentacyclic triterpenes on oxalate-induced changes in rat erythrocytes. Pharmacol Res 2000 42 313-316
93. Geetha T, Varalakshmi P, Latha R M. Effect of triterpenes from Crataeva nurvala stem bark on lipid peroxidation in adjuvant induced arthritis in rats. Pharmacol Res 1998 37 191-195
94. Vidya L, Varalakshmi P. Control of urinary risk factors of stones by betulin and lupeol in experimental hyperoxaluria. Fitoterapia 2000 71 535-543
95. Sudhahar V, Ashokkumar S, Varalakshmi P. Effect of lupeol and lupeol linoleate on lipemic hepatocellular aberrations in rats fed a high cholesterol diet. Mol Nutr Food Res 2006 50 1212-1219
96. Sudhahar V, Kumar S A., Sudharsan P T., Varalakshmi P. Protective effect of lupeol and its ester on cardiac abnormalities in experimental hypercholesterolemia. Vasc Pharmacol 2007 46 412-418
97. Prasad S, Kalra N, Shukla Y. Hepatoprotective effects of lupeol and mango pulp extract of carcinogen induced alteration in Swiss albino mice. Mol Nutr Food Res 2007 51 352-359
98. Preetha S P., Kanniappan M, Selvakumar E, Nagaraj M, Varalakshmi P. Lupeol ameliorates aflatoxin B1-induced peroxidative hepatic damage in rats. Comp Biochem Physiol C Toxicol Pharmacol 2006 143 333-339
99. Nagaraj M, Sunitha S, Varalakshmi P. Effect of lupeol, a pentacyclic triterpene, on the lipid peroxidation and antioxidant status in rat kidney after chronic cadmium exposure. J Appl Toxicol 2000 20 413-417
100. Sunitha S, Nagaraj M, Varalakshmi P. Hepatoprotective effect of lupeol and lupeol linoleate on tissue antioxidant defence system in cadmium-induced hepatotoxicity in rats. Fitoterapia 2001 72 516-523
101. Saleem M, Alam A, Arifin S, Shah M S., Ahmed B, Sultana S. Lupeol, a triterpene, inhibits early responses of tumor promotion induced by benzoyl peroxide in murine skin. Pharmacol Res 2001 43 127-134
102. Nigam N, Prasad S, Shukla Y. Preventive effects of lupeol on DMBA induced DNA alkylation damage in mouse skin. Food Chem Toxicol 2007 45 2331-2335
103. Miura N, Matsumoto Y, Miyairi S, Nishiyama S, Naganuma A. Protective effects of triterpene compounds against the cytotoxicity of cadmium in HepG2 cells. Mol Pharmacol 1999 56 1324-1328
104. Szuster-Ciesielska A, Kandefer-Szerszen M. Protective effects of betulin and betulinic acid against ethanol-induced cytotoxicity in HepG2 cells. Pharmacol Rep 2005 57 588-595
105. Furtado R A., Rodrigues E P., Araujo F R., Oliveira W L., Furtado M A., Castro M B., Cunha W R., Tavares D C. Ursolic acid and oleanolic acid suppress preneoplastic lesions induced by 1, 2-dimethylhydrazine in rat colon. Toxicol Pathol 2008 36 576-580
106. Liu J, Wu Q, Lu Y F., Pi J. New insights into generalized hepatoprotective effects of oleanolic acid: key roles of metallothionein and Nrf2 induction. Biochem Pharmacol 2008 76 922-928
107. Eggler A L., Gay K A., Mesecar A D. Molecular mechanisms of natural products in chemoprevention: induction of cytoprotective enzymes by Nrf2. Mol Nutr Food Res 2008 52 (Suppl.1) S84-S94
108. Lee K H., Nam G W., Kim S H., Lee S H. Phytocomponents of triterpenoids, oleanolic acid and ursolic acid, regulated differently the progressing of epidermal keratinocytes via PPAR-a pathway. Exp Dermatol 2006 15 66-73
109. Woelfle U L. M., Kraus M, Leuner K, Kersten A, Simon-Haarhaus B, Scheffler A, Martin S F., Müller W E., Nashan D, Schempp C M. Triterpenes promote keratinocyte differentiation in vitro, ex vivo and in vivo. A role for the transient receptor potential canonical (subtype) 6. JID August 13 2009
110. Schmuth M, Jiang Y J., Dubrac S, Elias P M., Feingold K R. Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology. J Lipid Res 2008 49 499-509
111. Lim S W., Hong S P., Jeong S W., Kim B, Bak H, Ryoo H C., Lee S H., Ahn S K. Simultaneous effect of ursolic acid and oleanolic acid on epidermal permeability barrier function and epidermal keratinocyte differentiation via peroxisome proliferator-activated receptor-alpha. J Dermatol 2007 34 625-634
112. Muller M, Essin K, Hill K, Beschmann H, Rubant S, Schempp C M., Gollasch M, Boehncke W H., Harteneck C, Muller W E., Leuner K. Specific TRPC6 channel activation, a novel approach to stimulate keratinocyte differentiation. J Biol Chem 2008 283 33942-33954
113. Lee H Y., Chung H Y., Kim K H., Lee J J., Kim K W. Induction of differentiation in the cultured F9 teratocarcinoma stem cells by triterpene acids. J Cancer Res Clin Oncol 1994 120 513-518
114. Paik K J., Jeon S S., Chung H Y., Lee K H., Kim K W., Chung J K., Kim N D. Induction of differentiation of the cultured rat mammary epithelial cells by triterpene acids. Arch Pharm Res 1998 21 398-405
115. Hata K, Hori K, Murata J, Takahashi S. Remodeling of actin cytoskeleton in lupeol-induced B16 2F2 cell differentiation. J Biochem 2005 138 467-472
116. Ogiwara K, Hata K. Melanoma cell differentiation induced by lupeol separates into two stages: morphological and functional changes. Nat Med (Tokyo) 2009 63 323-326
117. Poon K H., Zhang J, Wang C, Tse A K., Wan C K., Fong W F. Betulinic acid enhances 1alpha,25-dihydroxyvitamin D3-induced differentiation in human HL-60 promyelocytic leukemia cells. Anticancer Drugs 2004 15 619-624
118. Hata K, Hori K, Takahashi S. Differentiation-and apoptosis-inducing activities by pentacyclic triterpenes on a mouse melanoma cell line. J Nat Prod 2002 65 645-648
119. Pisha E, Chai H, Lee I S., Chagwedera T E., Farnsworth N R., Cordell G A., Beecher C W., Fong H H., Kinghorn A D., Brown D M., Wani M C., Wall M E., Hieken T J., Das Gupta T K., Pezzuto J M. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med 1995 1 1046-1051
120. Udeani G O., Zhao G M., Geun Shin Y, Cooke B P., Graham J, Beecher C W., Kinghorn A D., Pezzuto J M. Pharmacokinetics and tissue distribution of betulinic acid in CD-1 mice. Biopharm Drug Dispos 1999 20 379-383
121. Jäger S, Laszczyk M N., Scheffler A. A preliminary pharmacokinetic study of betulin, the main pentacyclic triterpene from extract of outer bark of birch (Betulae alba cortex). Molecules 2008 13 3224-3235
122. Jäger S, Winkler K, Pfüller U, Scheffler A. Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of Viscum album L. Planta Med 2007 73 157-162
123. Prasad S, Kalra N, Shukla Y. Induction of apoptosis by lupeol and mango extract in mouse prostate and LNCaP cells. Nutr Cancer 2008 60 120-130
124. Saleem M, Maddodi N, Abu Zaid M, Khan N, bin Hafeez B, Asim M, Suh Y, Yun J M., Setaluri V, Mukhtar H. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis. Clin Cancer Res 2008 14 2119-2127
125. Raphael T J., Kuttan G. Effect of naturally occurring triterpenoids ursolic acid and glycyrrhizic acid on the cell-mediated immune responses of metastatic tumor-bearing animals. Immunopharmacol Immunotoxicol 2008 30 243-255
126. Lee I, Lee J, Lee Y H., Leonard J. Ursolic acid-induced changes in tumor growth, O2 consumption, and tumor interstitial fluid pressure. Anticancer Res 2001 21 2827-2833
127. Sawada N, Kataoka K, Kondo K, Arimochi H, Fujino H, Takahashi Y, Miyoshi T, Kuwahara T, Monden Y, Ohnishi Y. Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice. Br J Cancer 2004 90 1672-1678
128. Lee T K., Poon R T., Wo J Y., Ma S, Guan X Y., Myers J N., Altevogt P, Yuen A P. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model. Cancer Res 2007 67 8800-8809
129. Liu J. Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol 1995 49 57-68
130. Singh G B., Singh S, Bani S, Gupta B D., Banerjee S K. Anti-inflammatory activity of oleanolic acid in rats and mice. J Pharm Pharmacol 1992 44 456-458
131. Shin Y G., Cho K H., Chung S M., Graham J, Das Gupta T K., Pezzuto J M. Determination of betulinic acid in mouse blood, tumor and tissue homogenates by liquid chromatography-electrospray mass spectrometry. J Chromatogr B Biomed Sci Appl 1999 732 331-336
132. Guo M, Zhang S, Song F, Wang D, Liu Z, Liu S. Studies on the non-covalent complexes between oleanolic acid and cyclodextrins using electrospray ionization tandem mass spectrometry. J Mass Spectrom 2003 38 723-731
133. Strüh C, Jäger S, Schempp C M., Scheffler A, Martin S F. Solubilized triterpenes from mistletoe show anti-tumor effects on skin-derived cell lines. Planta Med 2008 74 1130
134. Kang H S., Park J E., Lee Y J., Chang I S., Chung Y I., Tae G. Preparation of liposomes containing oleanolic acid via micelle-to-vesicle transition. J Nanosci Nanotechnol 2007 7 3944-3948